InvestSMART

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

- Current share price for ANR : $0.010

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Investor Update 25 Mar 2015 11:22AM $0.540 $0.010 fallen by 98.15%
$3 Anatara Strengthens Board and Executive Team 24 Feb 2015 9:14AM $0.465 $0.010 fallen by 97.85%
$3 Half Year Accounts 23 Feb 2015 10:03AM n/a $0.010 n/a
$3 Successful Detach Trial Results 18 Feb 2015 9:06AM n/a $0.010 n/a
$3 Appendix 4C - quarterly 28 Jan 2015 6:56PM $0.300 $0.010 fallen by 96.67%
$3 Field Trials begin to support registration 19 Dec 2014 8:26AM $0.315 $0.010 fallen by 96.83%
$3 Manufacturing, clinical trial and European SME status update 17 Oct 2014 8:28AM $0.420 $0.010 fallen by 97.62%
$3 Admission to Official List 14 Oct 2014 6:04PM n/a $0.010 n/a

526 - 533 of 533 results

Page 22 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.